Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

M. Shafique · SciRah

Researcher profile · Semantic Scholar

M. Shafique

Share profile

M. Shafique — researcher profile on SciRah

h-index: 14
Works: 61
Citations: 1,063

Most-cited papers

Small Cell Lung Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology
A. Ganti, B. Loo, M. Bassetti, C. Blakely +30 more
2021The Journal of the National Comprehensive Cancer Network423 citations Open access
Semantic Scholar
Update on the Biology, Management, and Treatment of Small Cell Lung Cancer (SCLC)
A. Saltos, M. Shafique, A. Chiappori
2020Frontiers in Oncology132 citations Open access
Semantic Scholar
Phase 1/1b study of pembrolizumab plus vorinostat in advanced/metastatic non-small cell lung cancer
J. Gray, A. Saltos, T. Tanvetyanon, E. Haura +13 more
2019Clinical Cancer Research102 citations Open access
Semantic Scholar
A Phase II Trial of Selinexor (KPT‐330) for Metastatic Triple‐Negative Breast Cancer
M. Shafique, R. Ismail-Khan, M. Extermann, D. Sullivan +6 more
2019The Oncologist45 citations Open access
Semantic Scholar
Prospective Single-Arm Phase 1 and 2 Study: Ipilimumab and Nivolumab With Thoracic Radiation Therapy After Platinum Chemotherapy in Extensive-Stage Small Cell Lung Cancer
B. Perez, Sungjune Kim, Min-Hsuan Wang, A. Karimi +21 more
2020International Journal of Radiation Oncology, Biology, Physics43 citations Open access
Semantic Scholar
Combination checkpoint inhibitors for treatment of non-small-cell lung cancer: an update on dual anti-CTLA-4 and anti-PD-1/PD-L1 therapies
Sonam Puri, M. Shafique
2020Drugs in Context40 citations Open access
Semantic Scholar
A Phase Ib/II Study of Pepinemab in Combination with Avelumab in Advanced Non–Small Cell Lung Cancer
M. Shafique, T. Fisher, E. Evans, J. Leonard +17 more
2021Clinical Cancer Research27 citations
Semantic Scholar
Immunotherapy alone or chemo-immunotherapy as front-line treatment for advanced non-small cell lung cancer
M. Shafique, T. Tanvetyanon
2019Expert Opinion on Biological Therapy24 citations
Semantic Scholar
Immune Checkpoint Inhibitors in Early-Stage and Locally Advanced Non-Small Cell Lung Cancer
Sonam Puri, M. Shafique, J. Gray
2018Current Treatment Options in Oncology21 citations
Semantic Scholar
Phase I study of peposertib and avelumab with or without palliative radiotherapy in patients with advanced solid tumors
B. Perez, R. Aljumaily, T. Marron, M. Shafique +14 more
2024ESMO Open20 citations Open access
Semantic Scholar
Small Cell Lung Cancer, Version 2.2022
A. Ganti, B. Loo, M. Bassetti, C. Blakely +30 more
202120 citations
Semantic Scholar
Reduced-Intensity Allogeneic Transplantation Using Alemtuzumab from HLA-Matched Related, Unrelated, or Haploidentical Related Donors for Patients with Hematologic Malignancies
J. Kanda, G. Long, C. Gasparetto, M. Horwitz +7 more
2013Biology of Blood and Marrow Transplantation15 citations Open access
Semantic Scholar
Dose-Limiting Pulmonary Toxicity in a Phase 1/2 Study of Radiation and Chemotherapy with Ipilimumab Followed by Nivolumab for Patients With Stage 3 Unresectable Non-Small Cell Lung Cancer
C. Liveringhouse, K. Latifi, Amalin Asous, Nghi B. Lam +21 more
2023International Journal of Radiation Oncology, Biology, Physics14 citations
Semantic Scholar
Durvalumab: a potential maintenance therapy in surgery-ineligible non-small-cell lung cancer
M. Shafique, L. Robinson, S. Antonia
2018Cancer Management and Research14 citations Open access
Semantic Scholar
Optimizing Tarlatamab Delivery in Small Cell and Neuroendocrine Lung Cancer: Real-World Insights into Step-Up Dosing and Prophylactic Tocilizumab Use.
Utsav Joshi, Faustine Ong, Daniel Melzer, Joanna C. Ma +16 more
2025Clinical Lung Cancer12 citations
Semantic Scholar
Phase II randomized trial of first-line pembrolizumab and vorinostat in patients with metastatic NSCLC (mNSCLC).
A. Saltos, T. Tanvetyanon, B. Creelan, M. Shafique +12 more
202011 citations
Semantic Scholar
Osimertinib vs. afatinib as first-line treatment for patients with metastatic non-small cell lung cancer with an EGFR exon 19 deletion or exon 21 L858R mutation
Sophia Gilardone, R. Thapa, José Laborde, M. Shafique +10 more
2023Journal of Thoracic Disease10 citations Open access
Semantic Scholar
Enhanced Efficacy of Chemotherapy by Addition of Immune Checkpoint Inhibitors in Stage IV Large Cell Neuroendocrine Carcinoma of the Lung: A Real-World Analysis
Ling-Bin Meng, B. Cao, Rui Ji, Dung-Tsa Chen +2 more
2023Journal of Cancer10 citations Open access
Semantic Scholar
Results of a phase 1 dose-escalation study of AMV564, a novel T-cell engager, alone and in combination with pembrolizumab in patients with relapsed/refractory solid tumors.
N. Mettu, A. Starodub, S. Piha-Paul, R. Abdul-Karim +5 more
20219 citations
Semantic Scholar
Phase II randomized trial of first-line pembrolizumab and vorinostat in patients with metastatic NSCLC (mNSCLC): Final results.
A. Saltos, T. Tanvetyanon, B. Creelan, M. Shafique +11 more
2023Journal of Clinical Oncology8 citations
Semantic Scholar
A Prospective Single Arm Phase I/II Study: Consolidative Ipilimumab and Nivolumab with Thoracic Radiotherapy after Platinum Based Chemotherapy for Patients with Extensive-Stage Small Cell Lung Cancer
B. Perez, S.-W. Kim, T. Dilling, K. Latifi +14 more
2019International Journal of Radiation Oncology, Biology, Physics8 citations Open access
Semantic Scholar
Phase 1, open-label, dose-escalation study of M3814 + avelumab ± radiotherapy (RT) in patients (pts) with advanced solid tumors.
J. Bendell, M. Shafique, B. Perez, S. Chennoufi +3 more
2019Journal of Clinical Oncology6 citations
Semantic Scholar
Atezolizumab and Stereotactic Body Radiation in Metastatic, Recurrent, or Persistent Cervical Cancer: Results From a Phase 2 Multi-Institutional Study
K. Ahmed, A. Quick, H. Chon, J. Chern +13 more
2025International Journal of Radiation Oncology, Biology, Physics5 citations
Semantic Scholar
A phase I/IB trial of binimetinib in combination with erlotinib in NSCLC harboring activating KRAS or EGFR mutations.
A. Saltos, B. Creelan, T. Tanvetyanon, A. Chiappori +10 more
2023Lung Cancer5 citations
Semantic Scholar
Rapid Improvement Following Receipt of Infliximab in Steroid-refractory Durvalumab-Associated Grade 3 Pneumonitis
Sherri Y. Huang, A. Jordan, Dakota Jenneman, M. Shafique +1 more
2022Cureus5 citations Open access
Semantic Scholar
MA13.02 Phase II Study of Nivolumab and Ipilimumab Combined With Nintedanib in Recurrent Non-Small Cell Lung Cancer
S. Puri, T. Tanvetyanon, B. Creelan, M. Shafique +7 more
2021Journal of Thoracic Oncology4 citations Open access
Semantic Scholar
Interim results from a phase Ib/II study of pepinemab in combination with avelumab in advanced NSCLC patients following progression on prior systemic and/or anti-PDx therapies.
M. Shafique, T. Fisher, E. Evans, J. Leonard +16 more
2020Journal of Clinical Oncology4 citations
Semantic Scholar
ISL1: A Novel Neuroendocrine Subtype in Small Cell Lung Cancer Predicts Durable Response to Lurbinectedin.
M. Shields, Katherine G. Minton, Hilal Ozakinci, Tian-Hao Zhou +8 more
2026Molecular Cancer Therapeutics3 citations
Semantic Scholar
A phase II trial of AZD1775 plus carboplatin-paclitaxel in squamous cell lung cancer (SqCLC).
B. Pellini, Jian-Nong Li, M. Schell, M. Melendez +16 more
2024Journal of Clinical Oncology3 citations
Semantic Scholar
Preliminary results from CLASSICAL-Lung, a phase 1b/2 study of pepinemab (VX15/2503) in combination with avelumab in advanced NSCLC.
M. Shafique, T. Fisher, E. Evans, J. Leonard +11 more
2019Journal of Clinical Oncology3 citations
Semantic Scholar
Treatment of the Pregnant Patient with Breast Cancer
M. Shafique, M. Lee, Hyo S. Han
2017Southern medical journal (Birmingham, Ala. Print)3 citations Open access
Semantic Scholar
Real World Safety of Tarlatamab Step-Up Dosing in Extensive Stage Small Cell Lung Cancer
Faustine Ong, Utsav Joshi, Dan Melzer, Joanna C. Ma +14 more
2025Journal of Thoracic Oncology2 citations Open access
Semantic Scholar
Prospective Phase I/II Study of Radiation and Chemotherapy With Ipilimumab Followed by Nivolumab for Patients With Stage III Unresectable NSCLC.
C. Liveringhouse, Nghi B. Lam, S. Rosenberg, T. Dilling +13 more
2021International Journal of Radiation Oncology, Biology, Physics2 citations Open access
Semantic Scholar
A Phase 1b/2 Study of Pepinemab in Combination with Avelumab in Advanced Non-Small Cell Lung Cancer
M. Shafique, T. Fisher, E. Evans, J. Leonard +19 more
20212 citations
Semantic Scholar
372 Single-agent anti-tumor activity in relapsed/refractory solid tumors: interim data from the phase 1 solid tumor trial of AMV564, a novel T-cell engager
S. Piha-Paul, A. Starodub, R. Karim, M. Shafique +4 more
2020Journal for ImmunoTherapy of Cancer2 citations Open access
Semantic Scholar
Infectious Complications in Living-Donor Kidney Transplant Recipients Undergoing Multi-Modal Desensitization
Kristin C. Turza, M. Shafique, P. Lobo, R. Sawyer +3 more
2014Surgical Infections2 citations Open access
Semantic Scholar
Outcomes of patients with concurrent chronic lymphocytic leukemia and non-small cell lung carcinoma.
F. Amisha, Corbin Wright, J. Laborde, Samuel Reynolds +1 more
2025Journal of Clinical Oncology1 citations
Semantic Scholar
Validation of the Functional Assessment of Cancer Therapy – Immune Checkpoint Modulator 17-Item Symptom Index (FACT-ICM-17) to facilitate implementation in research and clinical care
L. Gudenkauf, D. Tometich, A. Hoogland, Xiao-Yin Li +14 more
2025Cancer1 citations Open access
Semantic Scholar
The final analysis of a phase I/II study of nivolumab, ipilimumab combined with nintedanib in advanced non-small cell lung cancer.
Sonam Puri, T. Tanvetyanon, B. Creelan, M. Shafique +8 more
2023Journal of Clinical Oncology1 citations Open access
Semantic Scholar
Safety Monitoring Activity During EGFR or Anaplastic Lymphoma Kinase Inhibitor Therapy for Patients With Lung Cancer
Avani M. Singh, Rafael Rubiera-Pebe, Y. Ahmad, M. Shafique +2 more
2023JCO Oncology Practice1 citations
Semantic Scholar
456 A phase 1b/2 umbrella study of anti-PD-1 sasanlimab in combination with other therapies for patients with stage IIIB/IV non-small cell lung cancer (NSCLC): The LANDSCAPE 1011 trial in progress
M. Boyer, S. Patel, Thomas Marron, N. Pavlakis +14 more
2021Journal for ImmunoTherapy of Cancer1 citations Open access
Semantic Scholar
Interim subgroup analysis for response by PD-L1 status of CLASSICAL-Lung, a phase Ib/II study of pepinemab (VX15/2503) in combination with avelumab in advanced NSCLC.
M. Shafique, T. Fisher, E. Evans, J. Leonard +16 more
20201 citations
Semantic Scholar
The IRX-2 regimen combined with nivolumab in recurrent/metastatic solid tumors: A phase 1b study to evaluate the safety, determine recommended phase 2 dose (RP2D), and investigate the biologic and clinical activity.
R. Jain, Jing-Song Zhang, Z. Eroglu, B. Creelan +9 more
2019Journal of Clinical Oncology1 citations
Semantic Scholar
P2.14-69 Lorlatinib Rescue Therapy for Life Threatening CNS Disease in Crizotinib-Resistant ROS1-Positive Non–Small Cell Lung Cancer (NSCLC)
A. Franke, V. Nair, M. Shafique, S. Mokhtari
2019Journal of Thoracic Oncology1 citations Open access
Semantic Scholar
Genomics-Based Brain Metastasis Risk Model in Stage II–III NSCLC after Concurrent Chemoradiotherapy and Consolidative Immunotherapy
K. Olabode, K. Shin, L. Martinka, Simran +15 more
2026International Journal of Radiation Oncology, Biology, Physics0 citations
Semantic Scholar
Real-World Prognostic Impact of PD-L1 Status in Unresectable NSCLC Treated with Concurrent Chemoradiation and Consolidative Immunotherapy
L. Martinka, K. Shin, K. Olabode, Simran +12 more
2026International Journal of Radiation Oncology, Biology, Physics0 citations
Semantic Scholar
Prognostic Impact of Comprehensive Genomic Profiling Stratified by STK11 Status in NSCLC Treated with the PACIFIC Regimen
L. Martinka, K. Shin, K. Olabode, Simran +15 more
2026International Journal of Radiation Oncology, Biology, Physics0 citations
Semantic Scholar
Impact of Immunotherapy Timing on Survival after Definitive Chemoradiotherapy in Unresectable Stage III NSCLC: A Systematic Review and Meta-Analysis
Simran, K. Shin, S. Panda, L. Martinka +13 more
2026International Journal of Radiation Oncology, Biology, Physics0 citations
Semantic Scholar
Clinical and Genomic Landscape of Recurrence after Concurrent Chemoradiotherapy and Adjuvant Immunotherapy in Unresectable NSCLC
K. Olabode, K. Shin, L. Martinka, Simran +15 more
2026International Journal of Radiation Oncology, Biology, Physics0 citations
Semantic Scholar
PP01.25: Leveraging p53 and MCL-1 as Therapeutic Targets in Small Cell Lung Cancer
Olivia C. Terry, Tian-Hao Zhou, M. Shafique, U. Rix +1 more
2026Journal of Thoracic Oncology0 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

A. Saltos×18
Invite
A. Saltos — researcher profile on SciRah
B. Creelan×18
Invite
B. Creelan — researcher profile on SciRah
T. Tanvetyanon×17
Invite
T. Tanvetyanon — researcher profile on SciRah
J. Gray×16
Invite
J. Gray — researcher profile on SciRah

×14

Invite

A. Chiappori — researcher profile on SciRah

Invite

E. Haura — researcher profile on SciRah

S. Rosenberg×9

Invite

S. Rosenberg — researcher profile on SciRah

Invite

J. Goldman — researcher profile on SciRah

Invite

S. Antonia — researcher profile on SciRah

Invite

R. Thapa — researcher profile on SciRah

Dung-Tsa Chen×6

Invite

Dung-Tsa Chen — researcher profile on SciRah

Invite

T. Dilling — researcher profile on SciRah